Arctic Therapeutics
Reykjavík
About Arctic Therapeutics
Arctic Therapeutics focuses on identifying genetic causes of major diseases and helping develop effective treatments for patients. Arctic Therapeutics aims to mitigate major risks linked to conventional drug development through the use of bioinformatics and artificial intelligence, ultimately lowering expenses and expediting the time to market. Arctic Therapeutics' research and development efforts are spearheaded by a group of global specialists in genetics, genomics, immunology, bioinformatics, and drug development
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $40.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Jan 2025)
- Website: arctictherapeutics.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/arctic-therapeutics-99025 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.